ghk-cu injections vs topical How Often to Inject GHK-Cu Topical vs Injection |
Description
(2019) 38:e99430

BPC-157 has never been submitted for marketing authorisation in Denmark, the European Union, the European Economic Area, or any other regulatory jurisdiction

This molecule also induced systemic wound healing in rats, mice, and pigs

To get a drug FDA approved, a company must conduct phase 1, 2 and 3 clinical trials proving safety and efficacy of the compound through a laborious, multi year and extremely costly process

They can provide recommendations on how to achieve a moderate weight in a healthy, sustainable manner
